Archives

IgA Nephropathy – From Pathogenesis to Current Management
About This Event
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. You will then take a deep dive into the current understanding of IgAN pathogenesis including the four hit cascade and the key role B-cells and APRIL (A PRoliferation-Inducing Ligand) play in driving disease progression.
Ocean Prime Family Restaurant
Featuring

Sara Nam, PharmD, BCCCP
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Sara Nam, PharmD, BCCCP is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) covering the Pacific Northwest Territory. Dr. Nam earned her Doctorate in Pharmacy from the University of Oklahoma and completed her postgraduate general pharmacy residency at Oklahoma State University Medical Center and her postgraduate critical care pharmacy residency at Memorial Hermann-Texas Medical Center. Prior to joining Otsuka, Dr. Nam practiced as an Emergency Medicine Pharmacy Specialist at the Methodist Health System in Dallas, TX and as a Portfolio Executive for Pharmacy Sourcing at Vizient, Inc. Dr. Nam holds a board certification in critical care pharmacotherapy.
Sara Nam, PharmD, BCCCP is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)